CRISPR/Cas9 gene editing: New hope for Alzheimer's disease therapeutics.

Bhardwaj S, Kesari KK, Rachamalla M, Mani S, Ashraf GM, Jha SK, Kumar P, Ambasta RK, Dureja H, Devkota HP, Gupta G, Chellappan DK, Singh SK, Dua K, Ruokolainen J, Kamal MA, Ojha S, Jha NK

Open source

DOI: 10.1016/j.jare.2021.07.001
Published: 2022 Sep
Container: Journal of advanced research
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.jare.2021.07.001,
  title = {CRISPR/Cas9 gene editing: New hope for Alzheimer's disease therapeutics.},
  author = {Bhardwaj S and Kesari KK and Rachamalla M and Mani S and Ashraf GM and Jha SK and Kumar P and Ambasta RK and Dureja H and Devkota HP and Gupta G and Chellappan DK and Singh SK and Dua K and Ruokolainen J and Kamal MA and Ojha S and Jha NK},
  year = {2022},
  journal = {Journal of advanced research},
  doi = {10.1016/j.jare.2021.07.001},
  url = {https://doi.org/10.1016/j.jare.2021.07.001}
}

RIS

TY  - JOUR
TI  - CRISPR/Cas9 gene editing: New hope for Alzheimer's disease therapeutics.
AU  - Bhardwaj S
AU  - Kesari KK
AU  - Rachamalla M
AU  - Mani S
AU  - Ashraf GM
AU  - Jha SK
AU  - Kumar P
AU  - Ambasta RK
AU  - Dureja H
AU  - Devkota HP
AU  - Gupta G
AU  - Chellappan DK
AU  - Singh SK
AU  - Dua K
AU  - Ruokolainen J
AU  - Kamal MA
AU  - Ojha S
AU  - Jha NK
PY  - 2022
JO  - Journal of advanced research
DO  - 10.1016/j.jare.2021.07.001
UR  - https://doi.org/10.1016/j.jare.2021.07.001
ER  -

APA

S, B., KK, K., M, R., S, M., GM, A., SK, J., P, K., RK, A., H, D., HP, D., G, G., DK, C., SK, S., K, D., J, R., MA, K., S, O., & NK, J. (2022). CRISPR/Cas9 gene editing: New hope for Alzheimer's disease therapeutics.. Journal of advanced research. https://doi.org/10.1016/j.jare.2021.07.001

Source records

pubmed · retrieved 2026-09-26T04:44:59.289Z